| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.028 | 0.5 |